Potential bias in medication adherence studies of prevalent users.
about
Real-world clinical and economic outcomes of liraglutide versus sitagliptin in patients with type 2 diabetes mellitus in the United States.Revisiting the washout period in the incident user study design: why 6-12 months may not be sufficientReal-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 Years.
P2860
Potential bias in medication adherence studies of prevalent users.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Potential bias in medication adherence studies of prevalent users.
@en
Potential bias in medication adherence studies of prevalent users.
@nl
type
label
Potential bias in medication adherence studies of prevalent users.
@en
Potential bias in medication adherence studies of prevalent users.
@nl
prefLabel
Potential bias in medication adherence studies of prevalent users.
@en
Potential bias in medication adherence studies of prevalent users.
@nl
P2093
P2860
P356
P1476
Potential bias in medication adherence studies of prevalent users.
@en
P2093
Chris L Bryson
Chuan-Fen Liu
Mark Perkins
Matthew L Maciejewski
Virginia Wang
P2860
P304
P356
10.1111/1475-6773.12043
P577
2013-02-13T00:00:00Z